Table 1.
Control group | Study group | p-value | |
---|---|---|---|
Age (years) | 54±8 | 57±7.5 | |
41–45 | 6 (24%) | 1 (6%) | 0.3012 |
46–50 | 3 (12%) | 1 (6%) | |
51–55 | 3 (12%) | 4 (23.5%) | |
56–60 | 3 (12%) | 5 (29.4%) | |
61–65 | 10 (40%) | 6 (35%) | |
Sex (M: F) | 2 (8%): 23 (92%) | 6 (35%): 11 (64.7%) | 0.0270 |
BMI (kg/m2) | 30.45±5.09 | 28.22±5.81 | |
Normal | 3 (12%) | 8 (47%) | 0.0375 |
Overweight | 9 (36%) | 3 (17.64%) | |
Obese | 13 (52%) | 6 (35.29%) | |
Concomitant diseases (Present: Absent) | 5 (20%):20 (80%) | 9 (52.9%):8 (47%) | 0.0262 |
Duration (years)* | |||
<1 | 3 (8%) | 1 (7.14%) | 0.1880 |
1–5 | 19 (76%) | 12 (70.58%) | |
6–10 | 2 (8%) | 3 (17.64%) | |
>11 | 1(4%) | 1 (7.14%) | |
Severity of disease | |||
Early | 4 (16%) | 2 (11.76%) | 0.2480 |
Mild | 4 (16%) | 3 (17.64%) | |
Moderate | 12 (48%) | 4 23.52%) | |
Severe | 5 (20%) | 8 (47.05%) |
Notes: All qualitative variables have been expressed as number (percentages), while quantitative variables have been expressed as Mean ± SD.